Category: Correspondence

Defending the CUD Diagnosis

From Dr. Jordan Tishler re: “A ‘Severe’ Case of Cannabis Use Disorder” While the DSM-V is clearly overly vague about the criteria for CUD, and the authors also do derive income from treating CUD, this patient also clearly has a problem.  He clearly wants to cut down but can’t, he’s having conflict in his primary relationships, potentially spending money he can’t afford, and is missing his obligations as a result of use. To assert that anyone treating CUD is suspect makes us suspect as clinicians treating people with Cannabis.  We all derive income from treating patients. Further, to assert...

Read More

Chronicling ‘Legalization’

A note (below) from David Downs, Cannabis Editor of the San Francisco Chronicle, reminds us that Tod Mikuriya, MD, tried in vain after Prop 215 passed in 1996 to get support for an “audit” (Tod’s term) that would have pressured state and county agencies to adjust their policies in accordance with the new law. The victory of Prop 215 had come as a stunning surprise —and a clear rebuke— to California politicos and bureaucrats. They were momentarily back on their heels, and Tod knew how important it was to keep the political momentum. Winning the election —creating a new...

Read More

What is Causing the Opiate Epidemic?

Here’s the conclusion of a piercing op-ed by Jessika Bohon in The Guardian (thanks to Doug McVay for sending): “…Addiction is a symptom for many young adults, not the root problem. The only group of 25 to 44 year olds that did not see their death rate go up was those with four-year college degrees. “It is critical that young Americans without college degrees also find employment that provides them with a decent income and a bit of the American dream. People without college degrees are 370% more likely to experience severe pain. But opioids and the medicalization of poverty cannot replace a job with a...

Read More

MBC to assess “impact of cannabis use on physicians”

From Stephen Robinson, MD, of the SCC to Howard Krauss, MD, of the Medical Board of California, June 14: Greetings, Dr. Krauss: I am writing as a Board member of the Society of Cannabis Clinicians. As you’re aware, guidelines developed by the Medical Board of California (MBC) governing both the recommending of medical cannabis, and its use, by physicians, has direct bearing on our members.  We were pleased you expressed a willingness to seek out research scientists who could provide the MBC with an objective foundation for their deliberations. At the last meeting of the Marijuana Task Force, I believe...

Read More

Cannabis and Immunotherapy

A reader in the UK asks: “Are there any studies or research notes on the use of medical marijuana while undergoing immunotherapy for the treatment of cancer?” The short answer from Joe D. Goldstrich, MD, FACC, June 17, 2017: “THC is sometimes used to down-regulate the immune system (auto-immune diseases). Based on this article and other research, in my opinion, it would not be appropriate to use THC in conjunction with immune therapies. I have worked with one patent who, despite my advice, decided to use cannabinoids with Keytruda, an immune therapy. His glioblastoma continued to grow. I have...

Read More